Clinical Trial Update: A Study of ADRX-0706 in Select Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study of ADRX-0706 in select advanced solid tumors is active/not recruiting, evaluating the investigational agent in triple-negative breast cancer, urot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Solid Tumors
• Triple-negative Breast Cancer
• Urothelial Carcinoma

Drugs mentioned

• ADRX-0706 (ADRX-0706)

Snippet

Sponsor: Adcentrx Therapeutics | Conditions: Solid Tumors, Triple Negative Breast Cancer (TNBC) | Phase 1 | Status: ACTIVE_NOT_RECRUITING